Skip to main content
PMC home page
EFSA Journal logoLink to EFSA Journal
. 2008 Jul 23;6(7):759. doi: 10.2903/j.efsa.2008.759

Toxicokinetics of Bisphenol A ‐ Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC)

European Food Safety Authority (EFSA)
PMCID: PMC10193634  PMID: 37213849

The content is available as a PDF (59.2 KB).

Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC) on a request from the Commission on the toxicokinetics of Bisphenol A. The EFSA Journal (2008) 759, 1–10.

Panel members: Fernando Aguilar, Herman Autrup, Sue Barlow, Laurence Castle, Riccardo Crebelli, Wolfgang Dekant, Karl‐Heinz Engel, Natalie Gontard, David Gott, Sandro Grilli, Rainer Gürtler, John Chr. Larsen, Catherine Leclercq, Jean‐Charles Leblanc, F. Xavier Malcata, Wim Mennes, Maria Rosaria Milana, Iona Pratt, Ivonne Rietjens, Paul Tobback, Fidel Toldrá.

Acknowledgement: The European Food Safety Authority wishes to thank Jean‐Lou Dorne and Detlef Woelfle for their assistance in the preparation of this opinion.

Adoption date: 9 July 2008

Published date: 23 July 2008

Question number: EFSA‐Q‐2008‐382

References

  1. Allegaert, K. , De, H.J. , Verbesselt, R. , Vanhole, C. , Devlieger, H. , and Tibboel, D. 2005. Intra‐ and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates. Acta Paediatr. 94, 1273–1279. [DOI] [PubMed] [Google Scholar]
  2. Arana A, Morton NS and Hansen TG (2001) Treatment with paracetamol in infants. Acta Anaesthesiol Scand 45: 20–29. [DOI] [PubMed] [Google Scholar]
  3. Benedetti, M.S. , Whomsley, R. , and Canning, M. 2007. Drug metabolism in the paediatric population and in the elderly. Drug Discov.Today 12, 599–610. [DOI] [PubMed] [Google Scholar]
  4. Blake, M.J. , Castro, L. , Leeder, J. S. , and Kearns, G.L. 2005. Ontogeny of drug metabolizing enzymes in the neonate. Semin.Fetal Neonatal Med. 10, 123–138. [DOI] [PubMed] [Google Scholar]
  5. Chen S, Beaton D, Nguyen N, Senekeo‐Effenberger K, Brace‐Sinnokrak E, Argikar U, Remmel R P, Trottier J, Barbier O, Ritter J K and Tukey R H (2005) Tissue‐specific, Inducible, and Hormonal Control of the Human UDP‐Glucuronosyltransferase‐1 (UGT1) Locus. Biol. Chem., 280, 37547–37557 [DOI] [PubMed] [Google Scholar]
  6. Domoradzki, J.Y. , Thornton, C. M. , Pottenger, L. H. , Hansen, S.C. , Card, T.L. , Markham, D.A. , Dryzga, M.D. , Shiotsuka, R.N. , and Waechter, J.M., Jr. 2004. Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal sprague‐dawley rats following oral administration. Toxicol.Sci. 77, 230–242. [DOI] [PubMed] [Google Scholar]
  7. Dorne, J.L. 2007. Human variability in hepatic and renal elimination: implications for risk assessment. J.Appl.Toxicol. 27, 411–420. [DOI] [PubMed] [Google Scholar]
  8. Dorne, J.L. , Walton, K. , and Renwick, A.G. 2001. Human variability in glucuronidation in relation to uncertainty factors for risk assessment. Food Chem.Toxicol. 39, 1153–1173. [DOI] [PubMed] [Google Scholar]
  9. Dorne, J.L. , Walton, K. , and Renwick, A.G. 2005. Human variability in xenobiotic metabolism and pathway‐related uncertainty factors for chemical risk assessment: a review. Food Chem.Toxicol. 43, 203–216. [DOI] [PubMed] [Google Scholar]
  10. Duanmu, Z. , Weckle, A. , Koukouritaki, S.B. , Hines, R.N. , Falany, J.L. , Falany, C.N. , Kocarek, T.A. , and Runge‐Morris, M. 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulphotransferases in pre‐ and postnatal human liver. J.Pharmacol.Exp.Ther. 316, 1310–1317. [DOI] [PubMed] [Google Scholar]
  11. EC (2003) European Commission EUR 20843 EN. European Union Risk Assessment Report 4,4′‐isopropylidenediphenol (bisphenol‐A), Volume 37. Editors: S.J. Munn et al. Luxembourg: Office for Official Publications of the European Communities; Environment and quality of life series Volume 37. Available through: ecb.jrc.it/DOCUMENTS/Existing‐Chemicals/RISK_ASSESSMENT/REPORT/bisphenolareport325.pdf; (June, 2008)
  12. EC (2008) Updated European Union Risk Assessment Report 4,4′‐isopropylidenediphenol (bisphenol‐a). Final approved version awaiting for publication. Available through: ecb.jrc.it/DOCUMENTS/Existing‐Chemicals/RISK_ASSESSMENT/ADDENDUM/bisphenola_add_325.pdf; (June, 2008)
  13. EFSA (2006) Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to 2,2‐BIS(4‐HYDROXYPHENYL)PROPANE (Bisphenol A) The EFSA Journal (2006) 428, 1‐ 75. www.efsa.europa.eu/EFSA/efsa_locale‐1178620753812_1178620772817.htm
  14. Ghibellini, G. , Leslie, E.M. , and Brouwer, K.L. 2006. Methods to evaluate biliary excretion of drugs in humans: an updated review. Mol.Pharm. 3, 198–211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hirom, P.C. , Millburn, P. , and Smith, R.L. 1976. Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 6, 55–64. [DOI] [PubMed] [Google Scholar]
  16. Levy, G. , Khanna, N.N. , Soda, D.M. , Tsuzuki, O. , and Stern, L. 1975. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulphate in relation to plasma bilirubin concentration and D‐glucaric acid excretion. Pediatrics 55, 818–825. [PubMed] [Google Scholar]
  17. Matsumoto, J. , Yokota, H. , Yuasa, A. 2002. Developmental increases in rat hepatic microsomal UDP‐glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect. 110, 193–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miller, R.P. , Roberts, R.J. , and Fischer, L.J. 1976. Acetaminophen elimination kinetics in neonates, children, and adults. Clin.Pharmacol.Ther. 19, 284–294. [DOI] [PubMed] [Google Scholar]
  19. Miners JO, Robson RA, Birkett DJ. 1986. Parcetamol metabolism in pregnancy. Br J Clin Pharmacol. 22, 359–362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nishiyama T, Ogura K, Nakano H, Kaku T, Takahashi E, Ohkubo Y, Sekine K, Hiratsuka A, Kadota S and Watabe T (2002) Sulphation of environmental estrogens by cytosolic human sulphotransferases. Drug Metab Pharmacokinet 17, 221–228. [DOI] [PubMed] [Google Scholar]
  21. Notarianni, L.J. , Oldham, H.G. , and Bennett, P.N. 1987. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br.J.Clin.Pharmacol. 24, 63–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pacifici, G.M. 2005. Sulphation of drugs and hormones in mid‐gestation human fetus. Early Hum.Dev. 81, 573–581. [DOI] [PubMed] [Google Scholar]
  23. Papini O, Bertucci C, Pereira da Cunha S, dos Santos, N A G and Lanchote V L (2006) Quantitative assay of lorazepam and its metabolite glucuronide by reverse‐phase liquid chromatography‐tandem mass spectrometry in human plasma and urine samples Journal of Pharmaceutical and Biomedical Analysis 40, 389–396. [DOI] [PubMed] [Google Scholar]
  24. Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman M, Stowe ZN. 2008. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 70, 2130–2136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pritchett J.J., Kuester R.K., Sipes, I.G. 2002. Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab Dispos. 30, 1180–1185. [DOI] [PubMed] [Google Scholar]
  26. Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ and Waechter JM, Jr. (2000) The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54, 3–18. [DOI] [PubMed] [Google Scholar]
  27. Renwick, A.G. , Dorne, J.L. , and Walton, K. 2000. An analysis of the need for an additional uncertainty factor for infants and children. Regul.Toxicol.Pharmacol. 31, 286–296. [DOI] [PubMed] [Google Scholar]
  28. Richard, K. , Hume, R , Kaptein, E , Stanley, E.L. , Visser, T.J. , and Coughtrie, M.W. 2001. Sulphation of thyroid hormone and dopamine during human development: ontogeny of phenol sulphotransferases and arylsulphatase in liver, lung, and brain. J.Clin.Endocrinol.Metab 86, 2734–2742. [DOI] [PubMed] [Google Scholar]
  29. Shimizu M, Ohta K, Matsumoto Y, Fukuoka M, Ohno Y and Ozawa S (2002) Sulphation of bisphenol A abolished its estrogenicity based on proliferation and gene expression in human breast cancer MCF‐7 cells. Toxicol In Vitro 16, 549–556. [DOI] [PubMed] [Google Scholar]
  30. Snyder RW, Maness SC, Gaido KW, Welsch F, Sumner SC and Fennell TR (2000) Metabolism and disposition of bisphenol A in female rats. Toxicol Appl Pharmacol 168, 225–234. [DOI] [PubMed] [Google Scholar]
  31. Strolin, B.M. , Whomsley, R. , and Baltes, E. 2006. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert.Opin.Drug Metab Toxicol. 2, 895–921. [DOI] [PubMed] [Google Scholar]
  32. Taylor, J.A. , Welshons, W.V. , Vom Saal, F.S. 2008. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod Toxicol. 25, 169–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vandenberg, L.N. , Hauser, R , Marcus, M , Olea, N. , and Welshons, W.V. 2007. Human exposure to bisphenol A (BPA). Reprod.Toxicol. 24, 139–177. [DOI] [PubMed] [Google Scholar]
  34. van der Marel CD, Anderson BJ, van Lingen RA, Holford NH, Pluim MA, Jansman FG, van den Anker JN and Tibboel D (2003) Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol 59, 243–251. [DOI] [PubMed] [Google Scholar]
  35. Völkel, W. , Colnot, T , Csanady, G.A. , Filser, J.G. , and Dekant, W. 2002. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem.Res.Toxicol. 15, 1281–1287. [DOI] [PubMed] [Google Scholar]
  36. Völkel W, Kiranoglu M, Fromme H. 2008. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol Lett. 179, 155–162. [DOI] [PubMed] [Google Scholar]
  37. Walton, K. , Dorne, J.L. , and Renwick, A.G. 2001. Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation. Food Chem.Toxicol. 39, 1175–1190. [DOI] [PubMed] [Google Scholar]
  38. Willhite, C.C. , Ball, G.L. , and McLellan, C.J. 2008. Derivation of a bisphenol A oral reference dose (RfD) and drinking‐water equivalent concentration. J.Toxicol.Environ.Health B Crit Rev. 11, 69–146. [DOI] [PubMed] [Google Scholar]
  39. Ye X, Kuklenyik Z, Needham LL and Calafat AM (2005) Quantification of urinary conjugates of bisphenol A, 2,5‐dichlorophenol, and 2‐hydroxy‐4‐methoxybenzophenone in humans by online solid phase extraction‐high performance liquid chromatography‐tandem mass spectrometry. Anal Bioanal Chem 383, 638–644. [DOI] [PubMed] [Google Scholar]
  40. Ye X, Kuklenyik Z, Needham LL and Calafat AM (2006) Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on‐line column‐switching‐high performance liquid chromatography‐isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 831, 110–115. [DOI] [PubMed] [Google Scholar]

Articles from EFSA Journal are provided here courtesy of Wiley

RESOURCES